Lucy Phillips

Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Fracture healing: mechanisms and interventions

CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD–Mineral and Bone Disorder

Wnt signaling in cancer

The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway

WNT–β-catenin signalling — a versatile player in kidney injury and repair

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways

Adeno-associated virus vector as a platform for gene therapy delivery

Structures and mechanisms of glycosyl hydrolases

Identification of unique release kinetics of serotonin from guinea‐pig and human enterochromaffin cells

Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway

Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities

LYSOSOMAL STORAGE DISEASES

Early chronic kidney disease–mineral bone disorder stimulates vascular calcification

Adeno-Associated Virus Gene Therapy for Liver Disease

The Fibroblast Growth Factor signaling pathway

Lectins:  Carbohydrate-Specific Proteins That Mediate Cellular Recognition

Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: The role of fibroblast growth factor 23

Transient Low-Dose Methotrexate Generates B Regulatory Cells That Mediate Antigen-Specific Tolerance to Alglucosidase Alfa

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy

Aging Differentially Affects Multiple Aspects of Vesicle Fusion Kinetics

Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease